跳至主要内容
临床试验/NCT05416892
NCT05416892已完成不适用

What is the Impact of Implementing Pharmaceutical Algorithms in the PharmaClass® Software, on the Handling the Patient's Medication Load, by the Clinical Pharmacist? Analysis of These Impacts Within 2 Geriatric Units of the CHU Brugmann Hospital

Murielle Surquin1 个研究点 分布在 1 个国家目标入组 109 人开始时间: 2021年9月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
109
试验地点
1
主要终点
Time

研究概览

简要总结

The clinical pharmacists present in the hospitalisation units aim to ensure the daily review of the drug prescriptions of hospitalized patients.

In order to optimize their work, the objective of this study would be to provide them with a clinical decision support tool via artificial intelligence in order to improve the patient's medication management. This study will test the Pharmaclass® software.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
75 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospitalized patient entering the SU06 or SU13 geriatrics unit of the Paul Brien site of the CHU Brugmann Hospital between November 16 2021 and April 15, 2022
  • Speaking French and/or Dutch
  • With chronic renal failure or taking at least one medicine for diabetes, heart, COPD, asthma, high blood pressure, epilepsy, atrial fibrillation, osteoporosis, high cholesterol, pain, parkinsonism, blood clotting, constipation, thyroid, depression, benign prostatic hypertrophy, gastric ulcer, Alzheimer's disease, cirrhosis as well as for electrolyte disorders (hypo or hypernatremia / potassium / calcium/magnesemia/phosphatemia).

排除标准

  • Patient who died or was transferred to another care unit during his/her hospitalization

结局指标

主要结局

Time

时间窗: 5 months

Time required to perform an intervention (pharmacist versus software)

Dosage compliance

时间窗: 5 months

Dosage compliance with existing recommendations and laboratory results/clinical parameters (pharmacist versus software)

Medication error severity

时间窗: 5 months

Severity of the medication error that could be avoided (pharmacist versus software)

Geriatrician approval

时间窗: 5 months

Number of interventions validated/refused by the geriatrician (pharmacist versus software)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Murielle Surquin

Head of Geriatry Department

Brugmann University Hospital

研究点 (1)

Loading locations...

相似试验